CN104380112B - 妊娠期糖尿病的母体生物标志物 - Google Patents

妊娠期糖尿病的母体生物标志物 Download PDF

Info

Publication number
CN104380112B
CN104380112B CN201380031224.2A CN201380031224A CN104380112B CN 104380112 B CN104380112 B CN 104380112B CN 201380031224 A CN201380031224 A CN 201380031224A CN 104380112 B CN104380112 B CN 104380112B
Authority
CN
China
Prior art keywords
fibronectin
glycosylated
psg
level
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380031224.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN104380112A (zh
Inventor
斯瑞尼瓦萨·R·纳加拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diabetomics Inc
Original Assignee
Diabetomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diabetomics Inc filed Critical Diabetomics Inc
Publication of CN104380112A publication Critical patent/CN104380112A/zh
Application granted granted Critical
Publication of CN104380112B publication Critical patent/CN104380112B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201380031224.2A 2012-04-13 2013-03-11 妊娠期糖尿病的母体生物标志物 Active CN104380112B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261623690P 2012-04-13 2012-04-13
US61/623,690 2012-04-13
PCT/US2013/030152 WO2013154709A1 (en) 2012-04-13 2013-03-11 Maternal biomarkers for gestational diabetes

Publications (2)

Publication Number Publication Date
CN104380112A CN104380112A (zh) 2015-02-25
CN104380112B true CN104380112B (zh) 2017-05-24

Family

ID=49325612

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380031224.2A Active CN104380112B (zh) 2012-04-13 2013-03-11 妊娠期糖尿病的母体生物标志物

Country Status (6)

Country Link
US (3) US8852873B2 (enExample)
EP (1) EP2836845B1 (enExample)
CN (1) CN104380112B (enExample)
ES (1) ES2684976T3 (enExample)
IN (1) IN2014DN09410A (enExample)
WO (1) WO2013154709A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160025737A1 (en) * 2014-07-25 2016-01-28 Diabetomics, Llc Biomarkers for assessment of preeclampsia
EP3271730B1 (en) * 2015-03-20 2019-10-09 IQ Products B.V. Novel marker for gestational diabetes
CN106706928A (zh) * 2017-01-19 2017-05-24 深圳大学 一种妊娠期糖尿病的早期预测标志物及其检测方法
CN107024590A (zh) * 2017-03-13 2017-08-08 新疆医科大学 一种诊断1型和2型糖尿病的血清蛋白标志物组
CN113495150A (zh) * 2020-03-19 2021-10-12 首都医科大学附属北京世纪坛医院 尿液白蛋白及其多肽片段在妊娠糖尿病中的应用
CN113514634A (zh) * 2020-04-09 2021-10-19 武汉市朗典精医生物科技有限公司 制备检测Adipo/SHBG双指标免疫层析试剂盒
CN113804879A (zh) * 2020-06-15 2021-12-17 北京康美天鸿生物科技有限公司 幽门螺旋杆菌IgM和IgG抗体联合检测试剂盒
EP4428535A1 (en) * 2023-03-09 2024-09-11 Servizo Galego de Saude Diagnosis, monitoring or prognosis of diabetes or prediabetes

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855242A (en) 1986-04-14 1989-08-08 Joslin Diabetes Center, Inc. Method of detecting antibodies
DE3800048A1 (de) 1987-05-14 1988-11-24 Boehringer Mannheim Gmbh Verfahren zur bestimmung eines antikoerpers in menschlichen koerperfluessigkeiten
US5645998A (en) 1988-12-13 1997-07-08 University Of Florida Research Foundation Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
US5175085A (en) 1990-02-20 1992-12-29 Board Of Regents, The University Of Texas System Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus
JP2727377B2 (ja) 1990-09-07 1998-03-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 糖尿病自己抗体の検出方法
US5512447A (en) 1990-09-07 1996-04-30 The Regents Of The University Of California Methods for the diagnosis and treatment of diabetes
US5674978A (en) 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
DE4129849A1 (de) 1991-02-14 1992-08-27 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen humane pankreas-inselzellen
IL101872A0 (en) 1991-05-15 1992-12-30 Univ Washington Cloning and expression of human islet glutamic acid decarboxylase autoantigen
US5674692A (en) 1991-09-06 1997-10-07 Baekkeskov; Steinunn Methods for diabetes susceptibility assessment in asymptomatic patients
US5200318A (en) 1992-05-13 1993-04-06 Miles Inc. Diagnosis of IDDM with a panel of immunoreagents
US5691448A (en) 1992-12-03 1997-11-25 Baekkeskov; Steinunn Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
IL108587A (en) 1993-02-09 1998-01-04 Univ Monash Methods and kit for diagnosing diabetes and pre-diabetic conditions
ATE221200T1 (de) 1993-04-16 2002-08-15 Univ California Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
US5547847A (en) 1993-09-07 1996-08-20 University Of Washington Diagnosis of insulin-dependent diabetes
US5561049A (en) 1994-09-21 1996-10-01 Behringwerke Ag Method for detecting antibodies
US6391651B1 (en) 1995-08-11 2002-05-21 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Materials and methods for detection of insulin dependent diabetes
US5989551A (en) 1995-10-25 1999-11-23 The United States Of America As Represented By The Department Of Health And Human Services Materials and methods for detection and treatment of insulin-dependent diabetes
US5821334A (en) 1996-01-26 1998-10-13 Vanderbilt University Insulin-dependent diabetes mellitus-specific chimeric polypeptides
AU1989097A (en) 1996-03-06 1997-09-22 University Of Washington Diabetes mellitus 37 kd autoantigen protein-tyrosine phosphatase
US5670377A (en) * 1996-03-14 1997-09-23 Sansum Medical Research Foundation Method of diagnosing gestational diabetes
AUPO468597A0 (en) 1997-01-21 1997-02-13 Montech Medical Developments Pty Ltd Expression in yeast of antigenically active, recombinant hybrid glutamic acid decarboxylase
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
DE19839736A1 (de) 1998-09-01 2000-03-02 Roche Diagnostics Gmbh Humane monoklonale Antikörper gegen Inselzellantigen IA-2
EP1340077B1 (en) 2000-10-17 2006-01-25 Besst-Test ApS Assay for directly detecting an inflammatory indicator in a body fluid sample
AU2002256168B2 (en) 2001-04-10 2007-09-20 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
US20050130245A1 (en) 2001-09-17 2005-06-16 Syn X Pharma, Inc. Diagnosis and treatment of early pre-type-1 diabetes utilizing neuronal proteins
AU2003237312A1 (en) 2002-05-29 2003-12-19 University Of Washington Mutants of gad65 and ian5 relating to diabetes
FR2847263B1 (fr) 2002-11-18 2006-01-13 Commissariat Energie Atomique Polynucleotide specifique de la cellule pancreatique beta des ilots de langerhans
US9557325B2 (en) 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
ATE518886T1 (de) 2003-06-09 2011-08-15 Redox Reactive Reagents L L C Verfahren zur änderung der bindungsspezifität von plasmaproteinen durch oxidations- reduktionsreaktionen
CA2529759A1 (en) 2003-06-20 2005-10-13 University Of Florida Biomarkers for differentiating between type 2 and type 2 diabetes
TW200508609A (en) 2003-07-15 2005-03-01 Bioarray Solutions Ltd Detection of cell membrane-associated proteins using membrane fragments displayed on encoded microparticle arrays
US7323346B2 (en) * 2003-08-14 2008-01-29 The General Hospital Corporation Screening for gestational disorders
SE0400683D0 (sv) * 2004-03-19 2004-03-19 Forskarpatent I Syd Ab Use of modified extracellular matrix proteins in diagnosis and treatment of a atherosclerosis
CA2575675A1 (en) * 2004-07-30 2006-03-09 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
ITRM20050398A1 (it) 2005-07-26 2007-01-27 Gian Franco Bottazzo Metodo per la rilevazione di cellule t in pazienti neodiagnosticati per diabete di tipo 1.
US8691944B2 (en) * 2005-10-04 2014-04-08 The Research Foundation For The State University Of New York Fibronectin polypeptides and methods of use
WO2007062789A1 (en) * 2005-11-29 2007-06-07 F. Hoffmann-La Roche Ag Fibronectin as target/marker for insulin resistance
CN101416063A (zh) 2006-02-06 2009-04-22 拉帕波特家族医学科学研究所 用于诊断t1dm的方法和试剂盒
US20070224638A1 (en) 2006-03-27 2007-09-27 Institut Pasteur Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
US9023984B2 (en) 2006-12-29 2015-05-05 The Regents Of The University Of Colorado, A Body Corporate Diagnostic and therapeutic target for autoimmune diseases and uses thereof
DK2121905T3 (en) 2007-02-21 2016-05-17 Univercell Biosolutions HUMAN pancreatic beta-CELL LINES FOR DIAGNOSIS OF DIABETES
EP2198304B1 (en) 2007-09-06 2016-01-13 University of Washington Molecules and methods for treatment and detection of diabetes
WO2009045403A2 (en) * 2007-10-01 2009-04-09 The Board Of Trustees Of The Leland Stanford Junior University MENIN REGULATION OF β-ISLET CELL PROLIFERATION
WO2009097584A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
WO2009097579A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Gestational age dependent proteomic changes of human maternal serum for monitoring maternal and fetal health
WO2009099603A1 (en) * 2008-02-04 2009-08-13 Women & Infants Hospital Serum-based, diagnostic, biological assay to predict pregnancy disorders
US8722343B2 (en) 2008-11-21 2014-05-13 Carla Perego Methods and compositions for the diagnosis and treatment of diabetes
KR101067815B1 (ko) 2009-02-05 2011-09-27 서울대학교산학협력단 제1형 당뇨병의 신규한 진단 마커
WO2011085057A2 (en) 2010-01-06 2011-07-14 The Regents Of The University Of Colorado, A Body Corporate Methods for detecting insulin autoantibody
WO2013025759A1 (en) 2011-08-16 2013-02-21 Battelle Memorial Institute Peptide and protein biomarkers for type 1 diabetes mellitus

Also Published As

Publication number Publication date
US9383370B2 (en) 2016-07-05
EP2836845A1 (en) 2015-02-18
CN104380112A (zh) 2015-02-25
EP2836845A4 (en) 2015-11-18
US20140080157A1 (en) 2014-03-20
ES2684976T3 (es) 2018-10-05
US20130274123A1 (en) 2013-10-17
WO2013154709A1 (en) 2013-10-17
EP2836845B1 (en) 2018-05-09
US8852873B2 (en) 2014-10-07
IN2014DN09410A (enExample) 2015-07-17
US8975034B2 (en) 2015-03-10
US20150037822A1 (en) 2015-02-05

Similar Documents

Publication Publication Date Title
CN104380112B (zh) 妊娠期糖尿病的母体生物标志物
JP6096813B2 (ja) 乳癌診断用マルチバイオマーカーセット、その検出方法、及びそれに対する抗体を含む乳癌診断キット
US11215615B2 (en) Peptides, reagents and methods for detecting food allergy
CN102257390B (zh) 半乳凝素-3免疫测定法
WO2022083673A1 (zh) 食管癌的生物标志物及其应用
US20180238890A1 (en) Methods and materials for detection, diagnosis and management of ovarian cancer
JP2020515826A (ja) 抗体アッセイ
JP2018205327A (ja) 子癇前症を診断するための方法および組成物
JP2006511790A (ja) 羊膜内炎症のためのバイオマーカー
US10996228B2 (en) Biomarkers for assessment of preeclampsia
US20140147874A1 (en) Biomarkers of cardiac ischemia
CN109313193B (zh) 消化道癌的判定方法
US20110256641A1 (en) Methods and Systems for Detecting Free IgE
US8697368B2 (en) Diagnostic marker for lung cancer comprising HPαR as active ingredient
CN120334544B (zh) 鼻咽癌抗体标志物及其应用
KR101544085B1 (ko) 공복 혈당 장애 진단용 마커로서 ｇｄｆ15 및 이를 포함하는 공복 혈당 장애 진단키트
WO2014177701A1 (en) Process for diagnosing a human subject with diseases affecting the kidneys, or at risk of acquiring diseases affecting the kidneys
CN120847262A (zh) 尿液s100a8在动脉粥样硬化性肾动脉狭窄诊疗中的应用
US20160161489A1 (en) Urine-based immuncassay for urocirtub 3 abd duagbisus if skeeo aobea
HK1240319A1 (en) Biomarkers for assessment of preeclampsia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant